SKI Market

Indian Indices

Sensex

82,344.68 487.20
( 0.60%)

Global Indices

Nasdaq

49,020.90 -412.51
(-0.83%)

Dow Jones

6,999.25 28.02
(0.40%)

Hang Seng

53,273.44 -60.10
(-0.11%)

Nikkei 225

10,215.77 66.92
(0.66%)

Forex

USD-INR

91.65 0.01
(0.01%)

EUR-INR

108.74 0.34
(0.32%)

GBP-INR

125.29 0.27
(0.21%)

JPY-INR

0.59 0.01
(1.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gland Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

543245

INE068V01023

610.0166926

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAND

23.87

27602.47

EPS(TTM)

Face Value()

Div & Yield %

70.19

1.07

Back

asian paints ltd

NACL Industries consolidated net profit declines 82.89% in the September 2025 quarter

Oct 24,2025

Net profit of NACL Industries declined 82.89% to Rs 2.55 crore in the quarter ended September 2025 as against Rs 14.90 crore during the previous quarter ended September 2024. Sales rose 3.78% to Rs 456.94 crore in the quarter ended September 2025 as against Rs 440.31 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	456.94	440.31	4
OPM %	9.79	9.26	-
PBDT	31.61	27.11	17
PBT	23.90	20.30	18
NP	2.55	14.90	-83

82,344.68 487.20 ( 0.60%)

49,020.90 -412.51 (-0.83%)

6,999.25 28.02 (0.40%)

53,273.44 -60.10 (-0.11%)

10,215.77 66.92 (0.66%)

91.65 0.01 (0.01%)

108.74 0.34 (0.32%)

125.29 0.27 (0.21%)

0.59 0.01 (1.05%)